Subtype
Benign Lymphatic Vessel Neoplasm
CI-CAN-00001908Explore in graph →
Non-malignant4 active trials
- NCIt
- C6524
Loading cancer entity…
Subtype
CI-CAN-00001908Explore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05983159 | A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations(TARGET-VM) | recruiting | Phase 2 | 50 | Murdoch Childrens Research InstituteOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06239480 | SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations(SELVA) | active not recruiting | Phase 3 | 51 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07477548 | A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies | not yet recruiting | Phase 2 | 67 | Yonsei UniversityOTHER | 0 | Mar 17, 2026 | clinicaltrials |
Data updated 22 days agoSource updated May 5, 2026source: clinicaltrials
| NCT06892964 |
| Institution of an Italian Registry and Biobank for Biological Sample Collection(IReg-LM) |
| recruiting |
| N/A |
| 70 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Mar 25, 2025 |
| clinicaltrials |